^
BIOMARKER:

MET amplification

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Renal Cell Carcinoma
Gastric Cancer
Lung Adenocarcinoma
Gastric Adenocarcinoma
Colorectal Cancer
GastroEsophageal Cancer
Glioblastoma
Hepatocellular Cancer
Lung Cancer
Head and Neck Cancer
Gallbladder Cancer
Solid Tumor
Sarcoma
Biliary Tract Cancer
Cholangiocarcinoma
Pancreatic Cancer
HER2 Positive Breast Cancer
Gastroesophageal Junction Adenocarcinoma
crizotinib
savolitinib
TPX-0022
tepotinib
crizotinib + osimertinib
APL-101
gefitinib + savolitinib
erlotinib + gefitinib + icotinib
RG3638
capmatinib
osimertinib + savolitinib
gefitinib + CT053PTSA
SCC244
gefitinib + tepotinib
TQ-B3101
bevacizumab + crizotinib
U3-1402
c-MET inhibitor
AMG 102
cediranib
selpercatinib
osimertinib + HQP8361
HQP8361
CKD-702
afatinib
Immunotherapy
lorlatinib
JNJ-38877605
erlotinib
SGX523
gefitinib
cetuximab
panitumumab
trastuzumab
osimertinib